Audio

Who benefits most from aspirin to prevent CVD and colorectal cancer?

J Fam Pract. 2016 May;65(5):audio
By
Doug Campos-Outcalt, MD, MPA
Author and Disclosure Information

In this audiocast, Doug Campos-Outcalt, MD, MPA, discusses the US Preventive Services Task Force (USPSTF)’s latest guideline regarding the use of low-dose aspirin to prevent cardiovascular disease and colorectal cancer.

 

Recommended Reading

FDA approves first leadless pacemaker
MDedge Family Medicine
USPSTF updates guideline for preventive aspirin therapy
MDedge Family Medicine
Drug-eluting stent recipients can safely have surgery sooner
MDedge Family Medicine
Standard incubation can miss P. acnes in infective endocarditis
MDedge Family Medicine
VIDEO: HOPE-3 bolsters primary prevention in intermediate-risk patients
MDedge Family Medicine
DANAMI 3-iPOST: No significant benefit with ischemic postconditioning after STEMI
MDedge Family Medicine
Psoriasis tied to abdominal aortic aneurysm in nationwide study
MDedge Family Medicine
Ticagrelor cuts post-MI events in diabetes patients
MDedge Family Medicine
PPI cuts GI events from low- and high-dose aspirin
MDedge Family Medicine
Earlier bariatric surgery may improve cardiovascular outcomes
MDedge Family Medicine

Related Articles